LSP Or Life Sciences Partners

Institutional venture firmpart of EQTSEC exempt reporting adviserClassification probable· AmsterdamLSPVC.COM

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

In the firm's own words, from its website.

Reported fund assets
$720M
the adviser's own Form ADV total
New companies, 12 mo
3
Investment team
11
Latest vintage
2015
Contact decision makers
More
Ask DFX about thisView relationshipsFind contactsInvestments (43)Team (19)Funds
As of · the latest observation of this organization; filed figures are as of its latest Form ADV

11 additional team members, 37 additional co-investors and affiliates, 46 additional investments, funds and LPs, 11 events, 1 verified contact (1 firm phone)

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. 3 companies
    new in 12 months

    3 new companies in the last 12 months.

    A firm writing cheques this quarter is one a founder can pitch now.

    Factfunding announcements, Form D, the firm's portfolio pageFor Founders, co-investorsInvestments →
  2. 1 company
    portfolio raising

    One portfolio company has new financing on record in 6 months without this firm named on the round; the latest on 28 Aug 2026 ($550M sold on Form D).

    A portfolio company raising again is a follow-on decision for the firm and a co-investment opening for others.

    FactSEC Form D filingsFor Co-investors, LPs, lendersInvestments →

People to know

View all people
  • Jeremy Coller
    Head and Chief Investment Officer of Coller EQT
    Why: Chief investment officer: owns the allocation decision
    No route on file yet
  • James Yu
    Partner, Head of Global Client Solutions
    Why: Partner: part of the investment decision
    No route on file yet
  • Rene Robert Kuijten
    Managing Director
    Why: Managing director
    No route on file yet

Relationship network

79 connected entities3 observed rounds

From financing rounds and every investor named in them, Form ADV and Form D filings, the firm's funds and team, and disclosed LP commitments in the venture capital graph. A round's amount is the size of the round, not money that moved between two investors.

Some relationships on this record are counted rather than named here. They open with the full profile.

Click any name or line for the rounds and sources behind it. Line weight is rounds together; dashed lines are inferred.

Reading the network
  • Sponsor
  • Company
  • Fund or vehicle
  • Person

Co-investors are read from the rounds: three or more shared rounds is a strong observed relationship, two a repeat co-investor, one a single round. Funds and people are structural. Nothing is scored that a reader cannot check.

Darker lines were active in the last 24 months or are current; lighter lines are older or undated.

How am I connected?

Name your firm, a company or a person, and DFX finds the published routes to LSP Or Life Sciences Partners: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.

See how you connect to LSP Or Life Sciences Partners

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Investing

43 companies on record, 3 new in 12 months
Investments on record
43 companies, 2 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
AirNexis Therapeutics, Inc.portfolio listingunknownunknownunknownunknownOct 1, 2026Fact Company website
Appirioportfolio listingunknownunknownunknownunknownOct 1, 2026Fact Company website
Apprenticeportfolio listingunknownunknownunknownunknownOct 1, 2026Fact Company website
Stated thesis versus observed behaviour
43 observed deals
Stated (the firm’s website)
Sectors
healthcare, biotech, medtech, climate
Stages
series b, growth, early, multi stage
Geography
europe, france, globally, japan, united states
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
series b 50%series c 50%
Stage at first entry
series b 50%series c 50%
Industries, each company once
Life sciences (1)
lead rate 67%follow-on rate 0%new companies, 12 months 3

Team

19 current, 1 departed
Decision makers
who to call first, and why; then everyone else by function
  • Jeremy Coller · Head and Chief Investment Officer of Coller EQT
    Why this person: Chief investment officer: owns the allocation decision; Named with investment responsibility
  • James Yu · Partner, Head of Global Client Solutions
    Why this person: Partner: part of the investment decision; Named with investment responsibility
  • Rene Robert Kuijten · Managing Director
    Why this person: Managing director; Named with investment responsibility

Ranked by the role the firm or its filing states, a route on file and deals led. Every reason is read from the record, never inferred. Routes are published by the person or the firm (their bio, the team page or a filing) and are revealed on a plan; data bought from a provider is never shown, and a route printed at a firm the person has since left is held back.

Investment team
19 current, 1 departed
Contacts
1 firm phone

1 firm phone on record, each with its source. Values open with the complete profile.

Funds and LPs

6 vehicles, 0 LPs disclosed
Funds and vehicles
6 reported, 3 no longer reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
Life Sciences Partners IV BvFundunknownUnknown$27.8M
Mar 22, 2023
5unknownunknown
Life Sciences Partners IV CvFundunknownUnknown$25.1M
Mar 22, 2023
17unknownunknown
Life Sciences Partners III BvFundunknownUnknown$11.1M
Mar 22, 2023
16unknownunknown
Limited partners
0 LPs, 0 disclosed commitments
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Known LPs and allocators
0 relationships across the firm's funds, from public pensions and the allocator graph
No allocator names this firm or its funds in a public disclosure DFX holds.

Relationships across DFX

90 co-investors
Co-investors
90 counted from shared deals, for the whole firm

Evidence and history

16 dated events, 47 observations from 2 sources
Timeline
16 dated events
  1. Mar 30, 2021
    LSP Dementia Fund first reported on Form ADV by LSP Or Life Sciences Partners (Venture Capital Fund), GAV $5,491,005
    Fund first reported on Form ADVFundsFactLSP Dementia FundForm ADV
  2. Mar 29, 2018
    Life Sciences Partners 6 Cv first reported on Form ADV by LSP Or Life Sciences Partners (Venture Capital Fund)
    Fund first reported on Form ADVFundsFactLife Sciences Partners 6 CvForm ADV
  3. Mar 29, 2018
    LSP Bioventures Cv no longer reported on Form ADV by LSP Or Life Sciences Partners
    Fund no longer reportedFundsInferenceLSP Bioventures CvForm ADV
  4. Mar 29, 2018
    LSP Health Economics Fund B Cv no longer reported on Form ADV by LSP Or Life Sciences Partners
    Fund no longer reportedFundsInferenceLSP Health Economics Fund B CvForm ADV
  5. Mar 29, 2018
    LSP Health Economics Fund Cv no longer reported on Form ADV by LSP Or Life Sciences Partners
    Fund no longer reportedFundsInferenceLSP Health Economics Fund CvForm ADV
Identity and regulatory footprint
Address, phone, Form ADV filing and ownersForm ADV filed Mar 22, 2023 · 9 private fundsShow
Headquarters
Amsterdam, Netherlandsadviserinfo.sec.gov
Office address
unknownadviserinfo.sec.gov
Business phone
unknownadviserinfo.sec.gov
Website
LSPVC.COM
SEC adviser type
Exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
unknown
Latest Form ADV
Mar 22, 2023
Private funds reported
9 (9 venture capital funds)adviserinfo.sec.gov
Private fund gross assets, adviser total
$720Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Owners on Schedule A
EQT Life Sciences Group Bv (Sole Shareholder), owns 75% or more; EQT Treasury Ab (Sole Shareholder), owns 75% or more; EQT Ab (Sole Shareholder), owns 75% or more
Classification history
Every classification this record has carried1 on recordShow
  1. Sep 12, 2026
    Institutional venture firm (probable, 80%)
    Venture manager, reported GAV $76M across 6 vehicles
Evidence
47 observations from 2 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC adviser typeExempt reporting adviserMar 22, 2023FactForm ADV
First Form ADV filing2012-03-30Mar 22, 2023FactForm ADV
Adv history loadedadv-hist-1Sep 12, 2026FactForm ADV
Latest Form ADV filing2023-03-22Mar 22, 2023FactForm ADV
Venture share of reported funds1Mar 22, 2023FactForm ADV
Business phoneMar 22, 2023FactForm ADV
Contact page urlSep 30, 2026FactFirm website
Contact page urlSep 16, 2026FactFirm website
DescriptionSep 30, 2026FactFirm website
DescriptionSep 16, 2026FactFirm website
DescriptionSep 12, 2026FactFirm website
HeadquartersAmsterdam, NetherlandsMar 22, 2023FactForm ADV
Office addressMar 22, 2023FactForm ADV
Legal formOther (specify)Mar 22, 2023FactForm ADV
Private funds reported9Mar 22, 2023FactForm ADV
Private fund gross assets (reported)$720MMar 22, 2023FactForm ADV
Stated geographyEurope, france, globally, japan, united states
“geography words on the home page”
Sep 30, 2026FactFirm website
Stated geographyEurope, france, globally, japan, united states
“geography words on the home page”
Sep 16, 2026FactFirm website
Stated geographyEurope, france, globally, japan, united states
“geography words on the home page”
Sep 12, 2026FactFirm website
Stated sectorsHealthcare, biotech, medtech, climate
“sector words on the home page”
Sep 30, 2026FactFirm website
Stated sectorsHealthcare, biotech, medtech, climate
“sector words on the home page”
Sep 16, 2026FactFirm website
Stated sectorsHealthcare, biotech, medtech, climate
“sector words on the home page”
Sep 12, 2026FactFirm website
Stated stagesSeries b, growth, early, multi stage
“stage words on the home page”
Sep 30, 2026FactFirm website
Stated stagesSeries b, growth, early, multi stage
“stage words on the home page”
Sep 16, 2026FactFirm website
Stated stagesSeries b, growth, early, multi stage
“stage words on the home page”
Sep 12, 2026FactFirm website
Team pageSep 30, 2026FactFirm website
Team pageSep 16, 2026FactFirm website
Team pageSep 12, 2026FactFirm website
Venture funds reported9Mar 22, 2023FactForm ADV
WebsiteMar 22, 2023FactForm ADV
Website resolved domaineqtgroup.comSep 30, 2026FactFirm website
Website resolved domaineqtgroup.comSep 16, 2026FactFirm website
Site titleSep 30, 2026FactFirm website
Site titleSep 16, 2026FactFirm website
Site titleSep 12, 2026FactFirm website
How this is scored
Scores, classification basis and filing advisersInstitutional venture firm, probable · 3 filing advisers share this firmShow
Importance
49
elevated
Active deployment
11
low
Emerging
0
low
Freshness
99
high
Institutional venture firm · probableSEC exempt reporting adviser

Venture manager, reported GAV $76M across 6 vehicles

One of 3 advisers that share lspvc.com; the firm is EQT. EQT Fund Management S.A.R.L, LSP Advisory Bv. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.

The inputs behind each score
importance
gav: 0.56 · funds: 0.75 · people: 0.36 · investments: 0.61 · co investors: 0
active deployment
investments 12m: 0.38 · fund raising 18m: 0 · people joined 12m: 0 · vintage within 3y: 0 · latest investment at: 2026-08-11
emerging manager
fund count: 9 · reported gav: $720M · first adv filing: 2012-03-30 · years since first filing: 14.5

Fits, record history and connections

scored matches for this investor, every identity change, every edge

Fits

1 scored match, best firstas of
  • score 34.2confidence 90%
    Why: stage fit; activity; cap table

Scored by DFX match engines from the record's observed portfolio, stage, geography and recent activity. A fit is a reason to look, not a mandate; the blockers say what the model could not confirm. Names and the evidence sentences show with the names on this page.

Record history

1 identity change, 1 dated event on the change ledger, latest event first
  • Grouped with firm
    2026-10-01
  • Adviser's first ADV filing
    2012-03-30source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.